-
1
-
-
34248591612
-
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
-
Roberts PJ, Der CJ: Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007,26(22):3291-3310. 10.1038/sj.onc.1210422
-
(2007)
Oncogene
, vol.26
, Issue.22
, pp. 3291-3310
-
-
Roberts, P.J.1
Der, C.J.2
-
2
-
-
45849130495
-
Ras oncogenes: split personalities
-
Karnoub AE, Weinberg RA: Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008,9(7):517-531. 10.1038/nrm2438
-
(2008)
Nat Rev Mol Cell Biol
, vol.9
, Issue.7
, pp. 517-531
-
-
Karnoub, A.E.1
Weinberg, R.A.2
-
3
-
-
77249119762
-
The landscape of somatic copy-number alteration across human cancers
-
Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry K, Pinchback R, Ligon A, Cho Y, Haery L, Greulich H, Reich M, Winckler W, Lawrence M, Weir B, Tanaka K, Chiang D, Bass A, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S: The landscape of somatic copy-number alteration across human cancers. Nature 2010,463(7283):899-905. 10.1038/nature08822
-
(2010)
Nature
, vol.463
, Issue.7283
, pp. 899-905
-
-
Beroukhim, R.1
Mermel, C.H.2
Porter, D.3
Wei, G.4
Raychaudhuri, S.5
Donovan, J.6
Barretina, J.7
Boehm, J.S.8
Dobson, J.9
Urashima, M.10
Mc Henry, K.11
Pinchback, R.12
Ligon, A.13
Cho, Y.14
Haery, L.15
Greulich, H.16
Reich, M.17
Winckler, W.18
Lawrence, M.19
Weir, B.20
Tanaka, K.21
Chiang, D.22
Bass, A.23
Loo, A.24
Hoffman, C.25
Prensner, J.26
Liefeld, T.27
Gao, Q.28
Yecies, D.29
Signoretti, S.30
more..
-
4
-
-
84859171807
-
MYC on the path to cancer
-
Dang CV: MYC on the path to cancer. Cell 2012,149(1):22-35. 10.1016/j.cell.2012.03.003
-
(2012)
Cell
, vol.149
, Issue.1
, pp. 22-35
-
-
Dang, C.V.1
-
5
-
-
77952576753
-
The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy
-
Larsson LG, Henriksson MA: The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy. Exp Cell Res 2010,316(8):1429-1437. 10.1016/j.yexcr.2010.03.025
-
(2010)
Exp Cell Res
, vol.316
, Issue.8
, pp. 1429-1437
-
-
Larsson, L.G.1
Henriksson, M.A.2
-
6
-
-
84862183087
-
Functional genomics identifies therapeutic targets for MYC-driven cancer
-
Toyoshima M, Howie HL, Imakura M, Walsh RM, Annis JE, Chang AN, Frazier J, Chau BN, Loboda A, Linsley PS, Cleary M, Park J, Grandori C: Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc Natl Acad Sci U S A 2012,109(24):9545-9550. 10.1073/pnas.1121119109
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, Issue.24
, pp. 9545-9550
-
-
Toyoshima, M.1
Howie, H.L.2
Imakura, M.3
Walsh, R.M.4
Annis, J.E.5
Chang, A.N.6
Frazier, J.7
Chau, B.N.8
Loboda, A.9
Linsley, P.S.10
Cleary, M.11
Park, J.12
Grandori, C.13
-
7
-
-
69549124720
-
Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function
-
Jiang H, Bower KE, Beuscher AE, Zhou B, Bobkov AA, Olson AJ, Vogt PK: Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function. Mol Pharmacol 2009,76(3):491-502. 10.1124/mol.109.054858
-
(2009)
Mol Pharmacol
, vol.76
, Issue.3
, pp. 491-502
-
-
Jiang, H.1
Bower, K.E.2
Beuscher, A.E.3
Zhou, B.4
Bobkov, A.A.5
Olson, A.J.6
Vogt, P.K.7
-
8
-
-
33144486890
-
Structural aspects of interactions within the Myc/Max/Mad network
-
Nair SK, Burley SK: Structural aspects of interactions within the Myc/Max/Mad network. Curr Top Microbiol Immunol 2006, 302:123-143.
-
(2006)
Curr Top Microbiol Immunol
, vol.302
, pp. 123-143
-
-
Nair, S.K.1
Burley, S.K.2
-
9
-
-
0027364326
-
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max
-
Amati B, Littlewood TD, Evan GI, Land H: The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 1993,12(13):5083-5087.
-
(1993)
EMBO J
, vol.12
, Issue.13
, pp. 5083-5087
-
-
Amati, B.1
Littlewood, T.D.2
Evan, G.I.3
Land, H.4
-
10
-
-
0027910469
-
Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain
-
Ferre-D'Amare AR, Prendergast GC, Ziff EB, Burley SK: Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature 1993,363(6424):38-45. 10.1038/363038a0
-
(1993)
Nature
, vol.363
, Issue.6424
, pp. 38-45
-
-
Ferre-D'Amare, A.R.1
Prendergast, G.C.2
Ziff, E.B.3
Burley, S.K.4
-
11
-
-
4544221109
-
Omomyc expression in skin prevents Myc-induced papillomatosis
-
Soucek L, Nasi S, Evan GI: Omomyc expression in skin prevents Myc-induced papillomatosis. Cell Death Differ 2004,11(9):1038-1045. 10.1038/sj.cdd.4401443
-
(2004)
Cell Death Differ
, vol.11
, Issue.9
, pp. 1038-1045
-
-
Soucek, L.1
Nasi, S.2
Evan, G.I.3
-
12
-
-
0037096903
-
Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis
-
Soucek L, Jucker R, Panacchia L, Ricordy R, Tato F, Nasi S: Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis. Cancer Res 2002,62(12):3507-3510.
-
(2002)
Cancer Res
, vol.62
, Issue.12
, pp. 3507-3510
-
-
Soucek, L.1
Jucker, R.2
Panacchia, L.3
Ricordy, R.4
Tato, F.5
Nasi, S.6
-
13
-
-
79960623998
-
The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy
-
Savino M, Annibali D, Carucci N, Favuzzi E, Cole MD, Evan GI, Soucek L, Nasi S: The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy. PLoS One 2011,6(7):e22284. 10.1371/journal.pone.0022284
-
(2011)
PLoS One
, vol.6
, Issue.7
-
-
Savino, M.1
Annibali, D.2
Carucci, N.3
Favuzzi, E.4
Cole, M.D.5
Evan, G.I.6
Soucek, L.7
Nasi, S.8
-
14
-
-
84874835799
-
Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
-
Soucek L, Whitfield JR, Sodir NM, Masso-Valles D, Serrano E, Karnezis AN, Swigart LB, Evan GI: Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev 2013,27(5):504-513. 10.1101/gad.205542.112
-
(2013)
Genes Dev
, vol.27
, Issue.5
, pp. 504-513
-
-
Soucek, L.1
Whitfield, J.R.2
Sodir, N.M.3
Masso-Valles, D.4
Serrano, E.5
Karnezis, A.N.6
Swigart, L.B.7
Evan, G.I.8
-
15
-
-
53349103292
-
Modelling Myc inhibition as a cancer therapy
-
Soucek L, Whitfield J, Martins CP, Finch AJ, Murphy DJ, Sodir NM, Karnezis AN, Swigart LB, Nasi S, Evan GI: Modelling Myc inhibition as a cancer therapy. Nature 2008,455(7213):679-683. 10.1038/nature07260
-
(2008)
Nature
, vol.455
, Issue.7213
, pp. 679-683
-
-
Soucek, L.1
Whitfield, J.2
Martins, C.P.3
Finch, A.J.4
Murphy, D.J.5
Sodir, N.M.6
Karnezis, A.N.7
Swigart, L.B.8
Nasi, S.9
Evan, G.I.10
-
16
-
-
25444497278
-
The concept of synthetic lethality in the context of anticancer therapy
-
Kaelin WG Jr: The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 2005,5(9):689-698. 10.1038/nrc1691
-
(2005)
Nat Rev Cancer
, vol.5
, Issue.9
, pp. 689-698
-
-
Kaelin, W.G.1
-
17
-
-
79955592811
-
Harnessing synthetic lethal interactions in anticancer drug discovery
-
Chan DA, Giaccia AJ: Harnessing synthetic lethal interactions in anticancer drug discovery. Nat Rev Drug Discov 2011,10(5):351-364. 10.1038/nrd3374
-
(2011)
Nat Rev Drug Discov
, vol.10
, Issue.5
, pp. 351-364
-
-
Chan, D.A.1
Giaccia, A.J.2
-
18
-
-
79952409338
-
Targeting the missing links for cancer therapy
-
Polyak K, Garber J: Targeting the missing links for cancer therapy. Nat Med 2011,17(3):283-284. 10.1038/nm0311-283
-
(2011)
Nat Med
, vol.17
, Issue.3
, pp. 283-284
-
-
Polyak, K.1
Garber, J.2
-
19
-
-
67650471685
-
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers
-
Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS: Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009,361(2):123-134. 10.1056/NEJMoa0900212
-
(2009)
N Engl J Med
, vol.361
, Issue.2
, pp. 123-134
-
-
Fong, P.C.1
Boss, D.S.2
Yap, T.A.3
Tutt, A.4
Wu, P.5
Mergui-Roelvink, M.6
Mortimer, P.7
Swaisland, H.8
Lau, A.9
O'Connor, M.J.10
Ashworth, A.11
Carmichael, J.12
Kaye, S.B.13
Schellens, J.H.14
de Bono, J.S.15
-
20
-
-
77954032829
-
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval
-
Fong PC, Yap TA, Boss DS, Carden CP, Mergui-Roelvink M, Gourley C, De Greve J, Lubinski J, Shanley S, Messiou C, A'Hern R, Tutt A, Ashworth A, Stone J, Carmichael J, Schellens JH, de Bono JS, Kaye SB: Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval. J Clin Oncol 2010,28(15):2512-2519. 10.1200/JCO.2009.26.9589
-
(2010)
J Clin Oncol
, vol.28
, Issue.15
, pp. 2512-2519
-
-
Fong, P.C.1
Yap, T.A.2
Boss, D.S.3
Carden, C.P.4
Mergui-Roelvink, M.5
Gourley, C.6
De Greve, J.7
Lubinski, J.8
Shanley, S.9
Messiou, C.10
A'Hern, R.11
Tutt, A.12
Ashworth, A.13
Stone, J.14
Carmichael, J.15
Schellens, J.H.16
de Bono, J.S.17
Kaye, S.B.18
-
21
-
-
77955019276
-
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
-
Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, Friedlander M, Arun B, Loman N, Schmutzler RK, Wardley A, Mitchell G, Earl H, Wickens M, Carmichael J: Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 2010,376(9737):235-244. 10.1016/S0140-6736(10)60892-6
-
(2010)
Lancet
, vol.376
, Issue.9737
, pp. 235-244
-
-
Tutt, A.1
Robson, M.2
Garber, J.E.3
Domchek, S.M.4
Audeh, M.W.5
Weitzel, J.N.6
Friedlander, M.7
Arun, B.8
Loman, N.9
Schmutzler, R.K.10
Wardley, A.11
Mitchell, G.12
Earl, H.13
Wickens, M.14
Carmichael, J.15
-
22
-
-
80052389761
-
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
-
Gelmon KA, Tischkowitz M, Mackay H, Swenerton K, Robidoux A, Tonkin K, Hirte H, Huntsman D, Clemons M, Gilks B, Yerushalmi R, Macpherson E, Carmichael J, Oza A: Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study. Lancet Oncol 2011,12(9):852-861. 10.1016/S1470-2045(11)70214-5
-
(2011)
Lancet Oncol
, vol.12
, Issue.9
, pp. 852-861
-
-
Gelmon, K.A.1
Tischkowitz, M.2
Mackay, H.3
Swenerton, K.4
Robidoux, A.5
Tonkin, K.6
Hirte, H.7
Huntsman, D.8
Clemons, M.9
Gilks, B.10
Yerushalmi, R.11
Macpherson, E.12
Carmichael, J.13
Oza, A.14
-
23
-
-
77953626646
-
Genomic screening with RNAi: results and challenges
-
Mohr S, Bakal C, Perrimon N: Genomic screening with RNAi: results and challenges. Annu Rev Biochem 2010, 79:37-64. 10.1146/annurev-biochem-060408-092949
-
(2010)
Annu Rev Biochem
, vol.79
, pp. 37-64
-
-
Mohr, S.1
Bakal, C.2
Perrimon, N.3
-
24
-
-
0037124373
-
Synapsis of DNA ends by DNA-dependent protein kinase
-
DeFazio LG, Stansel RM, Griffith JD, Chu G: Synapsis of DNA ends by DNA-dependent protein kinase. EMBO J 2002,21(12):3192-3200. 10.1093/emboj/cdf299
-
(2002)
EMBO J
, vol.21
, Issue.12
, pp. 3192-3200
-
-
DeFazio, L.G.1
Stansel, R.M.2
Griffith, J.D.3
Chu, G.4
-
25
-
-
9744241712
-
A biochemically defined system for mammalian nonhomologous DNA end joining
-
Ma Y, Lu H, Tippin B, Goodman MF, Shimazaki N, Koiwai O, Hsieh CL, Schwarz K, Lieber MR: A biochemically defined system for mammalian nonhomologous DNA end joining. Mol Cell 2004,16(5):701-713. 10.1016/j.molcel.2004.11.017
-
(2004)
Mol Cell
, vol.16
, Issue.5
, pp. 701-713
-
-
Ma, Y.1
Lu, H.2
Tippin, B.3
Goodman, M.F.4
Shimazaki, N.5
Koiwai, O.6
Hsieh, C.L.7
Schwarz, K.8
Lieber, M.R.9
-
26
-
-
59449092185
-
Single-vector inducible lentiviral RNAi system for oncology target validation
-
Wiederschain D, Wee S, Chen L, Loo A, Yang G, Huang A, Chen Y, Caponigro G, Yao YM, Lengauer C, Sellers WR, Benson JD: Single-vector inducible lentiviral RNAi system for oncology target validation. Cell Cycle 2009,8(3):498-504. 10.4161/cc.8.3.7701
-
(2009)
Cell Cycle
, vol.8
, Issue.3
, pp. 498-504
-
-
Wiederschain, D.1
Wee, S.2
Chen, L.3
Loo, A.4
Yang, G.5
Huang, A.6
Chen, Y.7
Caponigro, G.8
Yao, Y.M.9
Lengauer, C.10
Sellers, W.R.11
Benson, J.D.12
-
27
-
-
69149108005
-
Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells
-
Molenaar JJ, Ebus ME, Geerts D, Koster J, Lamers F, Valentijn LJ, Westerhout EM, Versteeg R, Caron HN: Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells. Proc Natl Acad Sci U S A 2009,106(31):12968-12973. 10.1073/pnas.0901418106
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, Issue.31
-
-
Molenaar, J.J.1
Ebus, M.E.2
Geerts, D.3
Koster, J.4
Lamers, F.5
Valentijn, L.J.6
Westerhout, E.M.7
Versteeg, R.8
Caron, H.N.9
-
28
-
-
27244444199
-
A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function
-
Rottmann S, Wang Y, Nasoff M, Deveraux QL, Quon KC: A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function. Proc Natl Acad Sci U S A 2005,102(42):15195-15200. 10.1073/pnas.0505114102
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, Issue.42
-
-
Rottmann, S.1
Wang, Y.2
Nasoff, M.3
Deveraux, Q.L.4
Quon, K.C.5
-
29
-
-
0036261707
-
Sensing and repairing DNA double-strand breaks
-
Jackson SP: Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002,23(5):687-696. 10.1093/carcin/23.5.687
-
(2002)
Carcinogenesis
, vol.23
, Issue.5
, pp. 687-696
-
-
Jackson, S.P.1
-
30
-
-
0035695107
-
Involvement of DNA-dependent protein kinase in regulation of stress-induced JNK activation
-
Park SJ, Oh EJ, Yoo MA, Lee SH: Involvement of DNA-dependent protein kinase in regulation of stress-induced JNK activation. DNA Cell Biol 2001,20(10):637-645. 10.1089/104454901753340622
-
(2001)
DNA Cell Biol
, vol.20
, Issue.10
, pp. 637-645
-
-
Park, S.J.1
Oh, E.J.2
Yoo, M.A.3
Lee, S.H.4
-
31
-
-
0028902932
-
Loss of the catalytic subunit of the DNA-dependent protein kinase in DNA double-strand-break-repair mutant mammalian cells
-
Peterson SR, Kurimasa A, Oshimura M, Dynan WS, Bradbury EM, Chen DJ: Loss of the catalytic subunit of the DNA-dependent protein kinase in DNA double-strand-break-repair mutant mammalian cells. Proc Natl Acad Sci U S A 1995,92(8):3171-3174. 10.1073/pnas.92.8.3171
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, Issue.8
, pp. 3171-3174
-
-
Peterson, S.R.1
Kurimasa, A.2
Oshimura, M.3
Dynan, W.S.4
Bradbury, E.M.5
Chen, D.J.6
-
32
-
-
43949112650
-
DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein
-
An J, Yang DY, Xu QZ, Zhang SM, Huo YY, Shang ZF, Wang Y, Wu DC, Zhou PK: DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein. Mol Cancer 2008, 7:32. 10.1186/1476-4598-7-32
-
(2008)
Mol Cancer
, vol.7
, pp. 32
-
-
An, J.1
Yang, D.Y.2
Xu, Q.Z.3
Zhang, S.M.4
Huo, Y.Y.5
Shang, Z.F.6
Wang, Y.7
Wu, D.C.8
Zhou, P.K.9
-
33
-
-
0043193855
-
Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression
-
Karlsson A, Deb-Basu D, Cherry A, Turner S, Ford J, Felsher DW: Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression. Proc Natl Acad Sci U S A 2003,100(17):9974-9979. 10.1073/pnas.1732638100
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, Issue.17
, pp. 9974-9979
-
-
Karlsson, A.1
Deb-Basu, D.2
Cherry, A.3
Turner, S.4
Ford, J.5
Felsher, D.W.6
-
34
-
-
84871602994
-
c-Myc suppression of DNA double-strand break repair
-
Li Z, Owonikoko TK, Sun SY, Ramalingam SS, Doetsch PW, Xiao ZQ, Khuri FR, Curran WJ, Deng X: c-Myc suppression of DNA double-strand break repair. Neoplasia (New York, NY) 2012,14(12):1190-1202.
-
(2012)
Neoplasia (New York, NY)
, vol.14
, Issue.12
, pp. 1190-1202
-
-
Li, Z.1
Owonikoko, T.K.2
Sun, S.Y.3
Ramalingam, S.S.4
Doetsch, P.W.5
Xiao, Z.Q.6
Khuri, F.R.7
Curran, W.J.8
Deng, X.9
-
35
-
-
8844254050
-
Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries
-
Leahy JJ, Golding BT, Griffin RJ, Hardcastle IR, Richardson C, Rigoreau L, Smith GC: Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries. Bioorg Med Chem Lett 2004,14(24):6083-6087. 10.1016/j.bmcl.2004.09.060
-
(2004)
Bioorg Med Chem Lett
, vol.14
, Issue.24
, pp. 6083-6087
-
-
Leahy, J.J.1
Golding, B.T.2
Griffin, R.J.3
Hardcastle, I.R.4
Richardson, C.5
Rigoreau, L.6
Smith, G.C.7
-
36
-
-
84864875154
-
Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3 K
-
Munck JM, Batey MA, Zhao Y, Jenkins H, Richardson CJ, Cano C, Tavecchio M, Barbeau J, Bardos J, Cornell L, Griffin RJ, Menear K, Slade A, Thommes P, Martin NM, Newell DR, Smith GC, Curtin NJ: Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3 K. Mol Cancer Ther 2012,11(8):1789-1798. 10.1158/1535-7163.MCT-11-0535
-
(2012)
Mol Cancer Ther
, vol.11
, Issue.8
, pp. 1789-1798
-
-
Munck, J.M.1
Batey, M.A.2
Zhao, Y.3
Jenkins, H.4
Richardson, C.J.5
Cano, C.6
Tavecchio, M.7
Barbeau, J.8
Bardos, J.9
Cornell, L.10
Griffin, R.J.11
Menear, K.12
Slade, A.13
Thommes, P.14
Martin, N.M.15
Newell, D.R.16
Smith, G.C.17
Curtin, N.J.18
-
37
-
-
0026525775
-
DNA-activated protein kinase in Raji Burkitt's lymphoma cells. Phosphorylation of c-Myc oncoprotein
-
Iijima S, Teraoka H, Date T, Tsukada K: DNA-activated protein kinase in Raji Burkitt's lymphoma cells. Phosphorylation of c-Myc oncoprotein. Eur J Biochem 1992,206(2):595-603. 10.1111/j.1432-1033.1992.tb16964.x
-
(1992)
Eur J Biochem
, vol.206
, Issue.2
, pp. 595-603
-
-
Iijima, S.1
Teraoka, H.2
Date, T.3
Tsukada, K.4
-
38
-
-
27144472963
-
Downregulation of c-myc protein by siRNA-mediated silencing of DNA-PKcs in HeLa cells
-
An J, Xu QZ, Sui JL, Bai B, Zhou PK: Downregulation of c-myc protein by siRNA-mediated silencing of DNA-PKcs in HeLa cells. Int J Cancer 2005,117(4):531-537. 10.1002/ijc.21093
-
(2005)
Int J Cancer
, vol.117
, Issue.4
, pp. 531-537
-
-
An, J.1
Xu, Q.Z.2
Sui, J.L.3
Bai, B.4
Zhou, P.K.5
-
39
-
-
33746106937
-
MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species
-
Ray S, Atkuri KR, Deb-Basu D, Adler AS, Chang HY, Herzenberg LA, Felsher DW: MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species. Cancer Res 2006,66(13):6598-6605. 10.1158/0008-5472.CAN-05-3115
-
(2006)
Cancer Res
, vol.66
, Issue.13
, pp. 6598-6605
-
-
Ray, S.1
Atkuri, K.R.2
Deb-Basu, D.3
Adler, A.S.4
Chang, H.Y.5
Herzenberg, L.A.6
Felsher, D.W.7
-
40
-
-
0037012845
-
Genomic instability in mice lacking histone H2AX
-
Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Difilippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-Otero RD, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenzweig MC, Nussenzweig A: Genomic instability in mice lacking histone H2AX. Science 2002,296(5569):922-927. 10.1126/science.1069398
-
(2002)
Science
, vol.296
, Issue.5569
, pp. 922-927
-
-
Celeste, A.1
Petersen, S.2
Romanienko, P.J.3
Fernandez-Capetillo, O.4
Chen, H.T.5
Sedelnikova, O.A.6
Reina-San-Martin, B.7
Coppola, V.8
Meffre, E.9
Difilippantonio, M.J.10
Redon, C.11
Pilch, D.R.12
Olaru, A.13
Eckhaus, M.14
Camerini-Otero, R.D.15
Tessarollo, L.16
Livak, F.17
Manova, K.18
Bonner, W.M.19
Nussenzweig, M.C.20
Nussenzweig, A.21
more..
-
41
-
-
0037711771
-
Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks
-
Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A, Bonner RF, Bonner WM, Nussenzweig A: Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat Cell Biol 2003,5(7):675-679. 10.1038/ncb1004
-
(2003)
Nat Cell Biol
, vol.5
, Issue.7
, pp. 675-679
-
-
Celeste, A.1
Fernandez-Capetillo, O.2
Kruhlak, M.J.3
Pilch, D.R.4
Staudt, D.W.5
Lee, A.6
Bonner, R.F.7
Bonner, W.M.8
Nussenzweig, A.9
-
42
-
-
84881243042
-
gammaH2AX as a marker of DNA double strand breaks and genomic instability in human population studies
-
Valdiglesias V, Giunta S, Fenech M, Neri M, Bonassi S: gammaH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutat Res 2013,735(1):24-40.
-
(2013)
Mutat Res
, vol.735
, Issue.1
, pp. 24-40
-
-
Valdiglesias, V.1
Giunta, S.2
Fenech, M.3
Neri, M.4
Bonassi, S.5
-
43
-
-
34248356003
-
Cellular response to etoposide treatment
-
Montecucco A, Biamonti G: Cellular response to etoposide treatment. Cancer Lett 2007,252(1):9-18. 10.1016/j.canlet.2006.11.005
-
(2007)
Cancer Lett
, vol.252
, Issue.1
, pp. 9-18
-
-
Montecucco, A.1
Biamonti, G.2
-
44
-
-
33748199553
-
Conditional transgenic models define how MYC initiates and maintains tumorigenesis
-
Arvanitis C, Felsher DW: Conditional transgenic models define how MYC initiates and maintains tumorigenesis. Semin Cancer Biol 2006,16(4):313-317. 10.1016/j.semcancer.2006.07.012
-
(2006)
Semin Cancer Biol
, vol.16
, Issue.4
, pp. 313-317
-
-
Arvanitis, C.1
Felsher, D.W.2
-
45
-
-
80055000824
-
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
-
Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D, Qi J, Blatt K, Wunderlich M, Taylor MJ, Johns C, Chicas A, Mulloy JC, Kogan SC, Brown P, Valent P, Bradner JE, Lowe SW, Vakoc CR: RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 2011,478(7370):524-528. 10.1038/nature10334
-
(2011)
Nature
, vol.478
, Issue.7370
, pp. 524-528
-
-
Zuber, J.1
Shi, J.2
Wang, E.3
Rappaport, A.R.4
Herrmann, H.5
Sison, E.A.6
Magoon, D.7
Qi, J.8
Blatt, K.9
Wunderlich, M.10
Taylor, M.J.11
Johns, C.12
Chicas, A.13
Mulloy, J.C.14
Kogan, S.C.15
Brown, P.16
Valent, P.17
Bradner, J.E.18
Lowe, S.W.19
Vakoc, C.R.20
more..
-
46
-
-
80052955256
-
BET bromodomain inhibition as a therapeutic strategy to target c-Myc
-
Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS: BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011,146(6):904-917. 10.1016/j.cell.2011.08.017
-
(2011)
Cell
, vol.146
, Issue.6
, pp. 904-917
-
-
Delmore, J.E.1
Issa, G.C.2
Lemieux, M.E.3
Rahl, P.B.4
Shi, J.5
Jacobs, H.M.6
Kastritis, E.7
Gilpatrick, T.8
Paranal, R.M.9
Qi, J.10
Qi, J.11
Chesi, M.12
Schinzel, A.C.13
McKeown, M.R.14
Heffernan, T.P.15
Vakoc, C.R.16
Bergsagel, P.L.17
Ghobrial, I.M.18
Richardson, P.G.19
Young, R.A.20
Hahn, W.C.21
Anderson, K.C.22
Kung, A.L.23
Bradner, J.E.24
Mitsiades, C.S.25
more..
-
47
-
-
80053651202
-
Targeting MYC dependence in cancer by inhibiting BET bromodomains
-
Mertz JA, Conery AR, Bryant BM, Sandy P, Balasubramanian S, Mele DA, Bergeron L, Sims RJ 3rd: Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci U S A 2011,108(40):16669-16674. 10.1073/pnas.1108190108
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, Issue.40
-
-
Mertz, J.A.1
Conery, A.R.2
Bryant, B.M.3
Sandy, P.4
Balasubramanian, S.5
Mele, D.A.6
Bergeron, L.7
Sims, R.J.8
-
48
-
-
2342495721
-
Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway
-
Wang Y, Engels IH, Knee DA, Nasoff M, Deveraux QL, Quon KC: Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway. Cancer Cell 2004,5(5):501-512. 10.1016/S1535-6108(04)00113-8
-
(2004)
Cancer Cell
, vol.5
, Issue.5
, pp. 501-512
-
-
Wang, Y.1
Engels, I.H.2
Knee, D.A.3
Nasoff, M.4
Deveraux, Q.L.5
Quon, K.C.6
-
49
-
-
34447137342
-
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
-
Goga A, Yang D, Tward AD, Morgan DO, Bishop JM: Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. Nat Med 2007,13(7):820-827. 10.1038/nm1606
-
(2007)
Nat Med
, vol.13
, Issue.7
, pp. 820-827
-
-
Goga, A.1
Yang, D.2
Tward, A.D.3
Morgan, D.O.4
Bishop, J.M.5
-
50
-
-
82955203422
-
Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
-
Murga M, Campaner S, Lopez-Contreras AJ, Toledo LI, Soria R, Montana MF, D'Artista L, Schleker T, Guerra C, Garcia E, Barbacid M, Hidalgo M, Amati B, Fernandez-Capetillo O: Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat Struct Mol Biol 2011,18(12):1331-1335. 10.1038/nsmb.2189
-
(2011)
Nat Struct Mol Biol
, vol.18
, Issue.12
, pp. 1331-1335
-
-
Murga, M.1
Campaner, S.2
Lopez-Contreras, A.J.3
Toledo, L.I.4
Soria, R.5
Montana, M.F.6
D'Artista, L.7
Schleker, T.8
Guerra, C.9
Garcia, E.10
Barbacid, M.11
Hidalgo, M.12
Amati, B.13
Fernandez-Capetillo, O.14
-
51
-
-
84859167179
-
Deregulated MYC expression induces dependence upon AMPK-related kinase 5
-
Liu L, Ulbrich J, Muller J, Wustefeld T, Aeberhard L, Kress TR, Muthalagu N, Rycak L, Rudalska R, Moll R, Kempa S, Zender L, Eilers M, Murphy DJ: Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 2012,483(7391):608-612. 10.1038/nature10927
-
(2012)
Nature
, vol.483
, Issue.7391
, pp. 608-612
-
-
Liu, L.1
Ulbrich, J.2
Muller, J.3
Wustefeld, T.4
Aeberhard, L.5
Kress, T.R.6
Muthalagu, N.7
Rycak, L.8
Rudalska, R.9
Moll, R.10
Kempa, S.11
Zender, L.12
Eilers, M.13
Murphy, D.J.14
-
52
-
-
84856069665
-
A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis
-
Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM, Skinner SO, Xu Q, Li MZ, Hartman ZC, Rao M, Yu P, Dominguez-Vidana R, Liang AC, Solimini NL, Bernardi RJ, Yu B, Hsu T, Golding I, Luo J, Osborne CK, Creighton CJ, Hilsenbeck SG, Schiff R, Shaw CA, Elledge SJ, Westbrook TF: A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science 2012,335(6066):348-353. 10.1126/science.1212728
-
(2012)
Science
, vol.335
, Issue.6066
, pp. 348-353
-
-
Kessler, J.D.1
Kahle, K.T.2
Sun, T.3
Meerbrey, K.L.4
Schlabach, M.R.5
Schmitt, E.M.6
Skinner, S.O.7
Xu, Q.8
Li, M.Z.9
Hartman, Z.C.10
Rao, M.11
Yu, P.12
Dominguez-Vidana, R.13
Liang, A.C.14
Solimini, N.L.15
Bernardi, R.J.16
Yu, B.17
Hsu, T.18
Golding, I.19
Luo, J.20
Osborne, C.K.21
Creighton, C.J.22
Hilsenbeck, S.G.23
Schiff, R.24
Shaw, C.A.25
Elledge, S.J.26
Westbrook, T.F.27
more..
-
53
-
-
84874107696
-
Targeting DNA repair mechanisms in cancer
-
Furgason JM, el Bahassi M: Targeting DNA repair mechanisms in cancer. Pharmacol Ther 2013,137(3):298-308. 10.1016/j.pharmthera.2012.10.009
-
(2013)
Pharmacol Ther
, vol.137
, Issue.3
, pp. 298-308
-
-
Furgason, J.M.1
el Bahassi, M.2
-
54
-
-
77956369534
-
Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase
-
Yang D, Liu H, Goga A, Kim S, Yuneva M, Bishop JM: Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase. Proc Natl Acad Sci U S A 2010,107(31):13836-13841. 10.1073/pnas.1008366107
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, Issue.31
-
-
Yang, D.1
Liu, H.2
Goga, A.3
Kim, S.4
Yuneva, M.5
Bishop, J.M.6
-
55
-
-
0032167446
-
A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination
-
Gao Y, Chaudhuri J, Zhu C, Davidson L, Weaver DT, Alt FW: A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination. Immunity 1998,9(3):367-376. 10.1016/S1074-7613(00)80619-6
-
(1998)
Immunity
, vol.9
, Issue.3
, pp. 367-376
-
-
Gao, Y.1
Chaudhuri, J.2
Zhu, C.3
Davidson, L.4
Weaver, D.T.5
Alt, F.W.6
-
56
-
-
61749104245
-
A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining
-
van der Burg M, Ijspeert H, Verkaik NS, Turul T, Wiegant WW, Morotomi-Yano K, Mari PO, Tezcan I, Chen DJ, Zdzienicka MZ, van Dongen JJ, van Gent DC: A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining. J Clin Invest 2009,119(1):91-98.
-
(2009)
J Clin Invest
, vol.119
, Issue.1
, pp. 91-98
-
-
van der Burg, M.1
Ijspeert, H.2
Verkaik, N.S.3
Turul, T.4
Wiegant, W.W.5
Morotomi-Yano, K.6
Mari, P.O.7
Tezcan, I.8
Chen, D.J.9
Zdzienicka, M.Z.10
van Dongen, J.J.11
van Gent, D.C.12
-
57
-
-
0028960511
-
Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation
-
Blunt T, Finnie NJ, Taccioli GE, Smith GC, Demengeot J, Gottlieb TM, Mizuta R, Varghese AJ, Alt FW, Jeggo PA, Jackson SP: Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995,80(5):813-823. 10.1016/0092-8674(95)90360-7
-
(1995)
Cell
, vol.80
, Issue.5
, pp. 813-823
-
-
Blunt, T.1
Finnie, N.J.2
Taccioli, G.E.3
Smith, G.C.4
Demengeot, J.5
Gottlieb, T.M.6
Mizuta, R.7
Varghese, A.J.8
Alt, F.W.9
Jeggo, P.A.10
Jackson, S.P.11
-
58
-
-
0020663062
-
A severe combined immunodeficiency mutation in the mouse
-
Bosma GC, Custer RP, Bosma MJ: A severe combined immunodeficiency mutation in the mouse. Nature 1983,301(5900):527-530. 10.1038/301527a0
-
(1983)
Nature
, vol.301
, Issue.5900
, pp. 527-530
-
-
Bosma, G.C.1
Custer, R.P.2
Bosma, M.J.3
-
59
-
-
0028953951
-
DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect
-
Kirchgessner CU, Patil CK, Evans JW, Cuomo CA, Fried LM, Carter T, Oettinger MA, Brown JM: DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 1995,267(5201):1178-1183. 10.1126/science.7855601
-
(1995)
Science
, vol.267
, Issue.5201
, pp. 1178-1183
-
-
Kirchgessner, C.U.1
Patil, C.K.2
Evans, J.W.3
Cuomo, C.A.4
Fried, L.M.5
Carter, T.6
Oettinger, M.A.7
Brown, J.M.8
-
60
-
-
0032167545
-
Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity
-
Taccioli GE, Amatucci AG, Beamish HJ, Gell D, Xiang XH, Torres Arzayus MI, Priestley A, Jackson SP, Marshak Rothstein A, Jeggo PA, Herrera VL: Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity 1998,9(3):355-366. 10.1016/S1074-7613(00)80618-4
-
(1998)
Immunity
, vol.9
, Issue.3
, pp. 355-366
-
-
Taccioli, G.E.1
Amatucci, A.G.2
Beamish, H.J.3
Gell, D.4
Xiang, X.H.5
Torres Arzayus, M.I.6
Priestley, A.7
Jackson, S.P.8
Marshak Rothstein, A.9
Jeggo, P.A.10
Herrera, V.L.11
-
61
-
-
33744924482
-
Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441
-
Zhao Y, Thomas HD, Batey MA, Cowell IG, Richardson CJ, Griffin RJ, Calvert AH, Newell DR, Smith GC, Curtin NJ: Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res 2006,66(10):5354-5362. 10.1158/0008-5472.CAN-05-4275
-
(2006)
Cancer Res
, vol.66
, Issue.10
, pp. 5354-5362
-
-
Zhao, Y.1
Thomas, H.D.2
Batey, M.A.3
Cowell, I.G.4
Richardson, C.J.5
Griffin, R.J.6
Calvert, A.H.7
Newell, D.R.8
Smith, G.C.9
Curtin, N.J.10
-
62
-
-
57349194139
-
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
-
Engelman JA, Chen L, Tan X, Crosby K, Guimaraes AR, Upadhyay R, Maira M, McNamara K, Perera SA, Song Y, Chirieac LR, Kaur R, Lightbown A, Simendinger J, Li T, Padera RF, Garcia-Echeverria C, Weissleder R, Mahmood U, Cantley LC, Wong KK: Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med 2008,14(12):1351-1356. 10.1038/nm.1890
-
(2008)
Nat Med
, vol.14
, Issue.12
, pp. 1351-1356
-
-
Engelman, J.A.1
Chen, L.2
Tan, X.3
Crosby, K.4
Guimaraes, A.R.5
Upadhyay, R.6
Maira, M.7
McNamara, K.8
Perera, S.A.9
Song, Y.10
Chirieac, L.R.11
Kaur, R.12
Lightbown, A.13
Simendinger, J.14
Li, T.15
Padera, R.F.16
Garcia-Echeverria, C.17
Weissleder, R.18
Mahmood, U.19
Cantley, L.C.20
Wong, K.K.21
more..
-
63
-
-
51849111524
-
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations
-
Serra V, Markman B, Scaltriti M, Eichhorn PJ, Valero V, Guzman M, Botero ML, Llonch E, Atzori F, Di Cosimo S, Maira M, Garcia-Echeverria C, Parra JL, Arribas J, Baselga J: NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations. Cancer Res 2008,68(19):8022-8030. 10.1158/0008-5472.CAN-08-1385
-
(2008)
Cancer Res
, vol.68
, Issue.19
, pp. 8022-8030
-
-
Serra, V.1
Markman, B.2
Scaltriti, M.3
Eichhorn, P.J.4
Valero, V.5
Guzman, M.6
Botero, M.L.7
Llonch, E.8
Atzori, F.9
Di Cosimo, S.10
Maira, M.11
Garcia-Echeverria, C.12
Parra, J.L.13
Arribas, J.14
Baselga, J.15
-
64
-
-
51049109033
-
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
-
Maira SM, Stauffer F, Brueggen J, Furet P, Schnell C, Fritsch C, Brachmann S, Chene P, De Pover A, Schoemaker K, Fabbro D, Gabriel D, Simonen M, Murphy L, Finan P, Sellers W, Garcia-Echeverria C: Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther 2008,7(7):1851-1863. 10.1158/1535-7163.MCT-08-0017
-
(2008)
Mol Cancer Ther
, vol.7
, Issue.7
, pp. 1851-1863
-
-
Maira, S.M.1
Stauffer, F.2
Brueggen, J.3
Furet, P.4
Schnell, C.5
Fritsch, C.6
Brachmann, S.7
Chene, P.8
De Pover, A.9
Schoemaker, K.10
Fabbro, D.11
Gabriel, D.12
Simonen, M.13
Murphy, L.14
Finan, P.15
Sellers, W.16
Garcia-Echeverria, C.17
-
65
-
-
84907567262
-
Beyond DNA Repair: DNA-PK Function in Cancer
-
Goodwin JF, Knudsen KE: Beyond DNA Repair: DNA-PK Function in Cancer. Cancer Discovery 2014,4(10):1126-1139. 10.1158/2159-8290.CD-14-0358
-
(2014)
Cancer Discovery
, vol.4
, Issue.10
, pp. 1126-1139
-
-
Goodwin, J.F.1
Knudsen, K.E.2
-
66
-
-
51849098272
-
Drug discovery approaches targeting the PI3K/Akt pathway in cancer
-
Garcia-Echeverria C, Sellers WR: Drug discovery approaches targeting the PI3K/Akt pathway in cancer. Oncogene 2008,27(41):5511-5526. 10.1038/onc.2008.246
-
(2008)
Oncogene
, vol.27
, Issue.41
, pp. 5511-5526
-
-
Garcia-Echeverria, C.1
Sellers, W.R.2
-
68
-
-
0030442683
-
DNA damage detection by DNA dependent protein kinase and related enzymes
-
Jackson SP: DNA damage detection by DNA dependent protein kinase and related enzymes. Cancer Surv 1996, 28:261-279.
-
(1996)
Cancer Surv
, vol.28
, pp. 261-279
-
-
Jackson, S.P.1
-
69
-
-
84875243092
-
Identification of DNA-dependent protein kinase catalytic subunit as a novel interaction partner of lymphocyte enhancer factor 1
-
Shimomura A, Takasaki A, Nomura R, Hayashi N, Senda T: Identification of DNA-dependent protein kinase catalytic subunit as a novel interaction partner of lymphocyte enhancer factor 1. Med Mol Morphol 2013,46(1):14-19. 10.1007/s00795-012-0002-z
-
(2013)
Med Mol Morphol
, vol.46
, Issue.1
, pp. 14-19
-
-
Shimomura, A.1
Takasaki, A.2
Nomura, R.3
Hayashi, N.4
Senda, T.5
-
70
-
-
0030771917
-
Heat shock transcription factor 1 binds selectively in vitro to Ku protein and the catalytic subunit of the DNA-dependent protein kinase
-
Huang J, Nueda A, Yoo S, Dynan WS: Heat shock transcription factor 1 binds selectively in vitro to Ku protein and the catalytic subunit of the DNA-dependent protein kinase. J Biol Chem 1997,272(41):26009-26016. 10.1074/jbc.272.41.26009
-
(1997)
J Biol Chem
, vol.272
, Issue.41
-
-
Huang, J.1
Nueda, A.2
Yoo, S.3
Dynan, W.S.4
-
71
-
-
79955968629
-
Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer
-
Brenner JC, Ateeq B, Li Y, Yocum AK, Cao Q, Asangani IA, Patel S, Wang X, Liang H, Yu J, Palanisamy N, Siddiqui J, Yan W, Cao X, Mehra R, Sabolch A, Basrur V, Lonigro RJ, Yang J, Tomlins SA, Maher CA, Elenitoba-Johnson KS, Hussain M, Navone NM, Pienta KJ, Varambally S, Feng FY, Chinnaiyan AM: Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. Cancer Cell 2011,19(5):664-678. 10.1016/j.ccr.2011.04.010
-
(2011)
Cancer Cell
, vol.19
, Issue.5
, pp. 664-678
-
-
Brenner, J.C.1
Ateeq, B.2
Li, Y.3
Yocum, A.K.4
Cao, Q.5
Asangani, I.A.6
Patel, S.7
Wang, X.8
Liang, H.9
Yu, J.10
Palanisamy, N.11
Siddiqui, J.12
Yan, W.13
Cao, X.14
Mehra, R.15
Sabolch, A.16
Basrur, V.17
Lonigro, R.J.18
Yang, J.19
Tomlins, S.A.20
Maher, C.A.21
Elenitoba-Johnson, K.S.22
Hussain, M.23
Navone, N.M.24
Pienta, K.J.25
Varambally, S.26
Feng, F.Y.27
Chinnaiyan, A.M.28
more..
|